Baseline serum IL-40 correlated with rheumatoid factor (IgM) (p<0.01), anti-cyclic citrullinated peptide ... nm laser was depleted by a pulsed 775 nm STED laser in 2D donut shape. The fluorescence ...

For the first time, scientists have measured the shape of an electron in solids, opening the door to advances in quantum ...

Fintel reports that on January 13, 2025, JP Morgan upgraded their outlook for IGM Biosciences (NasdaqGS:IGMS) from ...

Bank of America Securities analyst Charlie CY Yang maintained a Hold rating on IGM Biosciences (IGMS – Research Report) today. The company’s ...

Researchers have innovatively merged protein structural data with genetic sequences to construct evolutionary trees, ...

Analyst Tom Mackinnon of BMO Capital maintained a Hold rating on IGM Financial (IGIFF – Research Report), retaining the price target of ...

(RTTNews) - Biotechnology company IGM Biosciences, Inc. (IGMS), Thursday announced a strategic update to halt further development of imvotamab, an IgM-based CD20 X CD3 bispecific antibody T cell ...

IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to achieve the desired results.

There are 203 funds or institutions reporting positions in IGM Biosciences. This is an decrease of 5 owner(s) or 2.40% in the last quarter. Average portfolio weight of all funds dedicated to IGMS ...